Your browser doesn't support javascript.
loading
Severe retinal degeneration in a patient with Canavan disease.
Benson, Matthew D; Plemel, David J A; Freund, Paul R; Lewis, James R; Sass, Jörn Oliver; Bähr, Luzy; Gemperle-Britschgi, Corinne; Ferreira, Patrick; MacDonald, Ian M.
Afiliação
  • Benson MD; Department of Ophthalmology and Visual Sciences, University of Alberta , Edmonton, Canada.
  • Plemel DJA; Department of Ophthalmology and Visual Sciences, University of Alberta , Edmonton, Canada.
  • Freund PR; Department of Ophthalmology and Visual Sciences, Dalhousie University , Halifax, Canada.
  • Lewis JR; Department of Ophthalmology and Visual Sciences, University of Alberta , Edmonton, Canada.
  • Sass JO; Research Group Inborn Errors of Metabolism, Department of Natural Science & Institute for Functional Gene Analytics (IFGA), Bonn-Rhein Sieg University of Applied Sciences , Rheinbach, Germany.
  • Bähr L; Clinical Chemistry & Biochemistry and Children's Research Center, University Children's Hospital , Zürich, Switzerland.
  • Gemperle-Britschgi C; Clinical Chemistry & Biochemistry and Children's Research Center, University Children's Hospital , Zürich, Switzerland.
  • Ferreira P; Division of Medical Genetics, Alberta Children's Hospital , Calgary, Canada.
  • MacDonald IM; Department of Ophthalmology and Visual Sciences, University of Alberta , Edmonton, Canada.
Ophthalmic Genet ; 42(1): 75-78, 2021 02.
Article em En | MEDLINE | ID: mdl-32975148
ABSTRACT

Background:

Canavan disease is an autosomal recessive, neurodegenerative disorder caused by mutations in ASPA, a gene encoding the enzyme aspartoacylase. Patients present with macrocephaly, developmental delay, hypotonia, vision impairment and accumulation of N-acetylaspartic acid. Progressive white matter changes occur in the central nervous system. The disorder is often fatal in early childhood, but milder forms exist. Materials and

methods:

Case report.

Results:

We present the case of a 31-year-old male with mild/juvenile Canavan disease who had severe vision loss due to a retinal degeneration resembling retinitis pigmentosa. Prior to this case, vision loss in Canavan disease had been attributed to optic atrophy based on fundoscopic evidence of optic nerve pallor. Investigations for an alternative cause for our patient's retinal degeneration were non-revealing.

Conclusion:

We wonder if retinal degeneration may not have been previously recognized as a feature of Canavan disease. We highlight findings from animal models of Canavan disease to further support the association between Canavan disease and retinal degeneration.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Degeneração Retiniana / Doença de Canavan Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Adult / Humans / Male Idioma: En Revista: Ophthalmic Genet Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Degeneração Retiniana / Doença de Canavan Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Adult / Humans / Male Idioma: En Revista: Ophthalmic Genet Ano de publicação: 2021 Tipo de documento: Article